STOCK TITAN

Weight Watchers Schedules Second Quarter 2026 Earnings Conference Call

(Moderate)
(Neutral)
Tags
conferences earnings date

Weight Watchers (NASDAQ: WW) plans to release its second quarter 2026 results, for the period ended June 30, 2026, after market close on Wednesday, August 5, 2026. The company will host an earnings conference call at 5:00 p.m. ET, with a live webcast and a replay available for at least 90 days on its corporate website.

Loading...
Loading translation...

Positive

  • None.

Negative

  • None.

Market Context

WW’s recent news record included 4 divergent reactions and 1 aligned reaction. That history adds con...
Analysis

WW’s recent news record included 4 divergent reactions and 1 aligned reaction. That history adds context to this Q2 reporting-date notice; moderate short positioning is a risk factor, while the scheduled results provide the next factual checkpoint.

Key Figures

Reporting period: Q2 2026 Results release timing: August 5, 2026 Conference call time: 5:00 p.m. ET +4 more
7 metrics
Reporting period Q2 2026 Results ended June 30, 2026
Results release timing August 5, 2026 After market close
Conference call time 5:00 p.m. ET August 5, 2026
Replay availability At least 90 days Webcast replay
Company experience More than 60 years Weight-management experience
Program ranking No. 1 U.S. doctor-recommended weight-loss program
Company founding Since 1963 Company history

Historical Context

5 past events · Latest: Jul 09 (Positive)
Pattern 5 events
Date Event Sentiment 24h Move Catalyst
Jul 09 Sam's Club collaboration Positive -4.0% Collaboration expanded affordable wellness access for Sam's Club members.
Jul 08 FlavCity collaboration Positive -0.6% Limited-edition product and Summer Strength Club expanded member engagement.
Jun 30 Medicare access program Positive -2.6% Medicare beneficiaries gained access to GLP-1 medications and behavioral support.
Jun 22 Health study support Positive -4.1% WW supported a nationwide study evaluating real-world weight-management outcomes.
Jun 16 UK partnership expansion Positive +0.5% Expanded UK partnership integrated clinical and behavioral weight management.

24h Move is the share-price change in the day after each event; other market factors may also have contributed.

Pattern Detected

WW's recent news history showed four negative 24-hour reactions to positive collaboration or program announcements, while one partnership produced a positive reaction.

Key Terms

glp-1
1 terms
glp-1 medical
"built for the GLP-1 era that combines scientific expertise, medication"
GLP-1 (glucagon-like peptide-1) is a natural hormone in the body that helps regulate blood sugar levels and appetite. Its significance to investors lies in its role as the basis for a class of medications that address conditions like type 2 diabetes and obesity, which are large and growing markets. Advances or investments in GLP-1-based treatments can signal opportunities in healthcare innovation and potentially impact pharmaceutical companies’ growth.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google

NEW YORK, July 23, 2026 (GLOBE NEWSWIRE) -- WW International, Inc. (NASDAQ: WW) (“Weight Watchers” or the “Company”) will release its results for the second quarter 2026 ended June 30, 2026, after market close on Wednesday, August 5, 2026.

Weight Watchers will host a conference call to discuss results at 5:00 p.m. ET the same day. The webcast of the conference call will be available on the Company’s corporate website, corporate.ww.com, under Events and Presentations. A replay of the webcast will be available on this site for at least 90 days.

About Weight Watchers
Weight Watchers is the global leader in science-backed weight management, offering an integrated support system built for the GLP-1 era that combines scientific expertise, medication, cutting-edge technology, and human connection. With more than 60 years of experience, Weight Watchers is the most studied commercial weight management program in the world, delivered through its No. 1 U.S. doctor-recommended weight-loss program. Its holistic, personalized approach also includes U.S.-based clinical interventions and access to GLP-1 medications when clinically appropriate, and a global network of coaches and community support. Since 1963, the company has led with science to deliver its members the personalized support they need to reach and sustain their goals. Members can access these solutions directly, or through Weight Watchers for Business’ full-spectrum platform for employers, health plans, and payers. In a landscape crowded with contradictory advice, isolating apps, and one-size-fits-all solutions, Weight Watchers offers a proven path forward that is rooted in research, grounded in empathy and designed to help every member feel better in their body and live a longer, healthier life. For more information, visit weightwatchers.com.

This news release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These forward-looking statements are based on management's current expectations and beliefs, as well as a number of assumptions concerning future events. These statements are subject to risks, uncertainties, assumptions and other important factors. Readers are cautioned not to put undue reliance on such forward-looking statements because actual results may vary materially from those expressed or implied. The reports filed by the Company pursuant to United States securities laws contain discussions of these risks and uncertainties. The Company assumes no obligation to, and expressly disclaims any obligation to, update or revise any forward-looking statements, whether as a result of new information, future events or otherwise. Readers are advised to review the Company's filings with the United States Securities and Exchange Commission (which are available on the SEC's EDGAR database at www.sec.gov and via the Company's website at corporate.ww.com).

For investor inquiries, please contact:
Anna Kate Heller
WeightWatchers@icrinc.com

For media inquiries, please contact:
Melissa Garbayo
melissa.garbayo@ww.com


FAQ

When will Weight Watchers (WW) report its Q2 2026 earnings results?

Weight Watchers (WW) will report its Q2 2026 earnings after market close on Wednesday, August 5, 2026. According to the company, the results cover the quarter ended June 30, 2026, and will be followed by a conference call.

What time is the Weight Watchers (WW) Q2 2026 earnings conference call?

The Weight Watchers (WW) Q2 2026 earnings conference call is scheduled for 5:00 p.m. ET on August 5, 2026. According to the company, the call will discuss quarterly results released after market close that same day.

How can investors access the Weight Watchers (WW) Q2 2026 earnings webcast?

Investors can access the Q2 2026 earnings webcast on Weight Watchers’ corporate website at corporate.ww.com under Events and Presentations. According to the company, a replay of the webcast will remain available on the site for at least 90 days.

Will a replay of the Weight Watchers (WW) Q2 2026 earnings call be available?

Yes, a replay of the Weight Watchers (WW) Q2 2026 earnings webcast will be available for at least 90 days. According to the company, the replay can be accessed through its corporate website in the Events and Presentations section.

Where can I find investor relations contact information for Weight Watchers (WW)?

Investor inquiries for Weight Watchers (WW) can be directed to Anna Kate Heller at WeightWatchers@icrinc.com. According to the company, this is the primary contact for shareholders and analysts seeking information about the Q2 2026 earnings and other investor matters.

What does Weight Watchers (WW) describe as its core business focus in 2026?

Weight Watchers (WW) describes itself as a global leader in science-backed weight management with an integrated support system for the GLP-1 era. According to the company, its approach combines medication, technology, clinical interventions, and coaching to deliver personalized weight management solutions.